This Founder Refunded $8,000 in Customer Orders in One Day. Here’s Why

What if your best marketing strategy was giving money back?

What if your best marketing strategy was giving money back?
Just the Tip: You can claim Social Security as early as 62, but your benefit grows every year you wait, including 8% per year between full retirement age and 70. Waiting from 62 to 70 can raise your monthly check by more than 75%. Delay if you’re healthy and have other income to draw from….
Human-caused climate change doubled the likelihood of the tinderbox weather conditions that sparked Canada’s massive summer wildfires and in turn angered U.S. President Donald Trump, according to a study released Thursday.And fire and climate scientists said Trump, who has talked about punishing Canada for poor fire management and sending days of choking smoke across the…
Every fund charges an annual expense ratio, a percentage of your assets taken as a fee regardless of performance. A 1% expense ratio on a $100,000 portfolio costs you $1,000 a year, while index funds from major low-cost brokerages commonly charge 0.03-0.05%. Check yours, because that difference compounds into tens of thousands over an investing…
Commercial vehicle loans recorded the highest early-stage delinquency among vehicle finance products, with portfolio at risk (PAR) 31-90 at 4.1 per cent in June 2026. Auto loans remained the best-performing asset class across both PAR 31-90 and PAR 91-180, according to a CRIF High Mark report. The vehicle finance portfolio grew at…
The S&P 500 Index ($SPX) (SPY) on Wednesday rose +0.26%, the Dow Jones Industrial Average ($DOWI) (DIA) fell -0.04%, and the Nasdaq 100 Index ($IUXX) (QQQ) rose +0.74%. September E-mini S&P futures (ESU26) rose +0.31%, and September E-mini Nasdaq futures (NQU26) rose +0.71%. Stocks closed higher on Wednesday due to strength in AI and chip stocks after CoreWeave and…
Shares of Moderna (MRNA +176.97%) soared on Wednesday after the vaccine maker announced potentially game-changing progress in the fight against cancer. Image source: Getty Images. Landmark results Moderna and Merck (MRK +12.60%) are co-developing an experimental mRNA-based therapy, intismeran autogene, that’s designed to activate an anti-tumor immune response based on the unique mutations of a…